The documents in this article are the current clinical pathways, patient group directions (PGDs), protocols, and master PGD/protocol authorisation sheet (Word: 125KB) for the NHS Pharmacy First Service. These will remain in place until 11:59pm on Tuesday 30 September 2025.
NHS England will publish updated clinical pathways, PGDs, protocol, and master PGD/protocol authorisation sheet on Monday 22 September 2025. These updated documents will come into effect from Wednesday 1 October 2025.
Pharmacy First Clinical Pathways V1.6 (PDF: 368KB)1a. Supply of nitrofurantoin capsules/tablets for the treatment of Urinary Tract Infection (PDF: 343KB)2a. Supply of aciclovir tablets/dispersible tablets for the treatment of shingles (herpes zoster) infection (PDF: 364KB)2b. Supply of valaciclovir tablets for the treatment of shingles (herpes zoster) infection (PDF: 376KB)3a. Protocol for the supply of topical hydrogen peroxide 1% cream (e.g. Crystacide® 1% cream) for the treatment of localised non-bullous impetigo (PDF: 353KB)3b. Supply of fusidic acid 20mg/g (2%) cream for the treatment of localised non-bullous impetigo (PDF: 335KB)3c. Supply of flucloxacillin capsules/oral solution/oral suspension for the treatment of widespread non-bullous impetigo (PDF: 376KB)3d. Supply of clarithromycin tablets/oral suspension/oral solution for the treatment of widespread non-bullous impetigo (PDF: 384KB)3e. Supply of erythromycin tablets/oral suspension/oral solution for the treatment of widespread non-bullous impetigo in pregnant individuals (aged 16 years and over) (PDF: 376KB)4a. Supply of flucloxacillin capsules/oral solution/oral suspension for the treatment of infected insect bite(s) and sting(s) (PDF: 385KB)4b. Supply of clarithromycin tablets/oral suspension/oral solution for the treatment of infected insect bite(s) and sting(s) (PDF: 392KB)4c. Supply of erythromycin tablets/oral suspension/oral solution for the treatment of infected insect bite(s) and sting(s) in pregnant individuals (aged 16 years and over) (PDF: 386KB)5a. Supply of phenoxymethylpenicillin (penicillin V) tablets/oral solution/oral suspension for the treatment of acute sore throat due to suspected streptococcal infection (PDF: 374KB)5b. Supply of clarithromycin tablets/oral suspension/oral solution for the treatment of acute sore throat due to suspected streptococcal infection (PDF: 401KB)5c. Supply of erythromycin tablets/oral suspension/oral solution for the treatment of acute sore throat due to suspected streptococcal infection in pregnant individuals (aged 16 years and over) (PDF: 392KB)6a. Supply of fluticasone furoate 27.5 micrograms/ dose nasal spray (e.g. Avamys® nasal spray suspension) for the treatment of acute sinusitis (rhinosinusitis) (PDF: 337KB)6b. Supply of mometasone furoate monohydrate 50 micrograms/dose nasal spray for the treatment of acute sinusitis (rhinosinusitis) (PDF: 336KB)6c. Supply of phenoxymethylpenicillin (penicillin V) tablets/oral solution/oral suspension for the treatment of acute bacterial sinusitis (rhinosinusitis) (PDF: 376KB)6d. Supply of clarithromycin tablets/oral suspension/oral solution for the treatment of acute bacterial sinusitis (rhinosinusitis) (PDF: 403KB)6e. Supply of clarithromycin tablets/oral suspension/oral solution for the treatment of acute bacterial sinusitis (rhinosinusitis) (PDF: 354KB)6f. Supply of doxycycline capsules/dispersible tablets for the treatment of acute bacterial sinusitis (rhinosinusitis) (PDF: 379KB)7a. Supply of Otigo® (phenazone 40mg/lidocaine hydrochloride 10mg/g) ear drops, solution for the symptomatic relief of pain due to acute otitis media (PDF: 343KB)7b. Supply of amoxicillin capsules/oral suspension/oral solution for the treatment of acute otitis media (PDF: 364KB)7c. Supply of clarithromycin tablets/oral suspension/oral solution for the treatment of acute otitis media (PDF: 387KB)7d. Supply of erythromycin tablets/oral suspension/oral solution for the treatment of acute otitis media (PDF: 375KB)